State Key Laboratory of Supramolecular Structure and Materials, Jilin University, No. 2699, Qianjin Street, Changchun, 130012 China.
Org Biomol Chem. 2013 Sep 21;11(35):5847-52. doi: 10.1039/c3ob41165f.
As a new type of cathepsin K inhibitor, azadipeptide nitriles have the characteristics of proteolytic stability and excellent inhibitory activity, but they exhibit barely any satisfactory selectivity. Great efforts have focused on improving their selectivity toward cathepsin K. In this sequential study, we report the further structural optimization, synthesis, molecular modeling, and in vitro enzymatic assays of a new series of potent and selective inhibitors of cathepsin K without the P2-P3 amide linker. Significant selective improvements were achieved for cathepsin K over L, S and B, and a triaryl meta-product possessed the favorable balance between potency (Ki = 0.29 nM) and selectivity of cathepsin K over cathepsin L (320-fold), S (1784-fold) and B (8566-fold). We undertook a covalent protein-ligand docking study to explain the improved selectivity of several representative compounds. Such a selectivity improvement would be useful to avoid harmful side effects in practical applications of these compounds.
作为一种新型的组织蛋白酶 K 抑制剂,阿扎肽腈具有蛋白酶稳定性和优异抑制活性的特点,但选择性几乎不能令人满意。人们致力于提高它们对组织蛋白酶 K 的选择性。在这项连续的研究中,我们报告了一系列新型的、没有 P2-P3 酰胺键的强效和选择性组织蛋白酶 K 抑制剂的进一步结构优化、合成、分子建模和体外酶活性测定。与 L、S 和 B 相比,对组织蛋白酶 K 的选择性有了显著提高,三芳基间位产物在效力(Ki = 0.29 nM)和对组织蛋白酶 K 相对于组织蛋白酶 L(320 倍)、S(1784 倍)和 B(8566 倍)的选择性之间具有良好的平衡。我们进行了共价蛋白-配体对接研究,以解释几个代表性化合物的选择性提高。这种选择性的提高对于避免这些化合物在实际应用中的有害副作用将是有用的。